6CM
ZURA icon

683 Capital Management’s Zura Bio ZURA Stock Holding History

683 Capital Management’s Portfolio ZURA Stock Details ZURA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$655K Sell
110,000
-149,165
-58% -$901K 0.03% 165
2025
Q4 		$1.36M Buy
+259,165
New +$1.02M 0.06% 120

Other funds holding ZURA

SCM
Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return
VA
VR Adviser New York $2.68B AUM 422.73% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
GPP
Great Point Partners Greenwich, Connecticut $435M AUM 318.81% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $3B AUM 46.72% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $3.61B AUM 203.3% 1-Year Est. Return
CC
Commodore Capital New York $1.73B AUM 298.96% 1-Year Est. Return
P
Pfizer New York $239M AUM 232.47% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
AAA
Affinity Asset Advisors New York $1.94B AUM 374.45% 1-Year Est. Return

683 Capital Management's ZURA Position: Q1 2026 in Review

683 Capital Management reduced its Zura Bio (ZURA) stake by 58% in Q1 2026, selling an estimated $901K and leaving 110,000 shares worth $655K. The position accounts for 0.03% of the portfolio, ranked #165.

683 Capital Management first reported a position in ZURA in Q4 2025 and has held it in 2 quarters since. The position peaked at $1.36M in Q4 2025. 94 funds tracked by Wall St. Rank hold ZURA as of Q1 2026.

  • 683 Capital Management held 110,000 shares of Zura Bio worth $655K as of Q1 2026.
  • 683 Capital Management sold 149,165 Zura Bio shares in Q1 2026, an estimated $901K.
  • Zura Bio made up 0.03% of 683 Capital Management's portfolio in Q1 2026, its #165 holding.
  • 683 Capital Management first reported a position in Zura Bio in Q4 2025 and has held it in 2 quarters since.
  • 683 Capital Management's Zura Bio position peaked at $1.36M in Q4 2025.
  • 94 funds tracked by Wall St. Rank held Zura Bio as of Q1 2026.

Based on 683 Capital Management's 13F filing for Q1 2026, filed 15 May 2026.